Funding Target Reached for LIfT BioSciences
Shadow Foundr celebrating as LifT BioSciences hits funding target to develop breakthrough cancer treatment. Alex Blyth, who lost his mother to pancreatic cancer, has successfully raised more than £250,000 to develop a pioneering cancer treatment that shares people’s innate immunity to cancer to help potentially cure cancer patients.